Behrman Capital Acquires Atherotech, Inc.

PEHUB -- Birmingham, Ala.-based Atherotech, a developer of a novel cholesterol test that was spun out of the University of Alabama, has been acquired by the New York-based investment firm Behrman Capital. Terms of the deal weren’t disclosed.